Review of the NIOSH Site Profile for the Idaho National Laboratory, Idaho – Revision 1
Total Page:16
File Type:pdf, Size:1020Kb
January 25, 2006 David Staudt Contracting Officer Centers for Disease Control & Prevention Acquisition and Assistance Field Branch P.O. Box 18070 626 Cochrans Mill Road – B-140 Pittsburgh, PA 15236-0295 Subject: Contract No. 200-2004-03805, Task Order 1: Draft Review of the NIOSH Site Profile for the Idaho National Laboratory, Idaho – Revision 1 Dear Mr. Staudt: S. Cohen & Associates (SC&A, Inc.) is pleased to submit its revised draft Review of the NIOSH Site Profile for the Idaho National Laboratory, Idaho. This report includes Attachment 3, “Summaries of Site Expert Reviews,” that was missing from Revision 0 of the document submitted to the Advisory Board and NIOSH on September 23, 2005. Revision 1 also includes an Attachment 5, “Issue Resolution Matrix for Findings and Key Observations.” Both of these attachments have undergone review by DOE. In preparing this deliverable, the authors have also made some minor editorial changes that do not affect the content of the original material. Sincerely, John Mauro, PhD, CHP Project Manager cc: P. Ziemer, PhD, Board Chairperson J. Broehm, NIOSH Advisory Board Members H. Behling, PhD, SC&A L. Wade, PhD, NIOSH K. Behling, SC&A L. Elliott, NIOSH D. Chan, PhD, SC&A J. Neton, PhD, NIOSH J. Lipzstein, PhD, SC&A S. Hinnefeld, NIOSH A. Makhijani, PhD, SC&A Z. Homoki-Titus, NIOSH S. Ostrow, PhD, SC&A A. Brand, NIOSH J. Fitzgerald, Saliant L. Shields, NIOSH K. Robertson-DeMers, CHP, Saliant Project File (ANIOS/001/05) Draft ADVISORY BOARD ON RADIATION AND WORKER HEALTH National Institute of Occupational Safety and Health Review of the NIOSH Site Profile for the Idaho National Laboratory, Idaho Contract No. 200-2004-03805 Task Order No. 1 SCA-TR-TASK1-0005 Prepared by S. Cohen & Associates 6858 Old Dominion Drive, Suite 301 McLean, Virginia 22101 Saliant, Inc. 5579 Catholic Church Road Jefferson, Maryland 21755 January 25, 2006 Disclaimer This document is made available in accordance with the unanimous desire of the Advisory Board on Radiation and Worker Health (ABRWH) to maintain all possible openness in its deliberations. However, the ABRWH and its contractor, SC&A, caution the reader that at the time of its release, this report is pre-decisional and has not been reviewed by the Board for factual accuracy or applicability within the requirements of 42CFR82. This implies that once reviewed by the ABRWH, the Board’s position may differ from the report’s conclusions. Thus, the reader should be cautioned that this report is for information only and that premature interpretations regarding its conclusions are unwarranted. Effective Date: Revision No. Document No. Page No. January 25, 2006 1 (Draft) SCA-TR-TASK1-0005 2 of 249 S. COHEN & ASSOCIATES: Document No. Technical Support for the Advisory Board on SCA-TR-TASK1-0005 Radiation & Worker Health Review of Effective Date: NIOSH Dose Reconstruction Program Draft – January 25, 2006 Revision No. 1 (Draft) REVIEW OF THE NIOSH SITE PROFILE FOR THE Page 2 of 249 IDAHO NATIONAL LABORATORY SITE, IDAHO Supersedes: Task Manager: _________________ Date:____________ Rev. 0 (Draft) Joe Fitzgerald Project Manager: _______________ Date:____________ John Mauro Effective Date: Revision No. Document No. Page No. January 25, 2006 1 (Draft) SCA-TR-TASK1-0005 3 of 249 TABLE OF CONTENTS Acronyms and Abbreviations ..........................................................................................................5 1.0 Executive Summary ...........................................................................................................14 1.1 Summary of Strengths............................................................................................22 1.2 Summary of Findings.............................................................................................24 1.3 Opportunities for Improvement .............................................................................27 2.0 Scope and Introduction ......................................................................................................30 3.0 Assessment Criteria and Method .......................................................................................33 3.1 Objectives ..............................................................................................................33 3.1.1 Objective 1: Completeness of Data Sources .............................................33 3.1.2 Objective 2: Technical Accuracy..............................................................33 3.1.3 Objective 3: Adequacy of Data.................................................................33 3.1.4 Objective 4: Consistency Among Site Profiles.........................................34 3.1.5 Objective 5: Regulatory Compliance ........................................................34 3.2 Assessment Methodology ......................................................................................35 4.0 Site Profile Strengths .........................................................................................................40 4.1 Completeness of Data Sources...............................................................................40 4.2 Technical Accuracy/Claimant-Favorability...........................................................41 4.3 Adequacy of Data ..................................................................................................42 4.4 Consistency Among the Site Profiles ....................................................................44 4.5 Regulatory Compliance .........................................................................................44 5.0 Vertical Issues ....................................................................................................................45 5.1 Discussion of Issues...............................................................................................45 5.1.1 Occupational Environmental Dose Issues .................................................45 5.1.2 Occupational Internal Dosimetry Issues ....................................................65 5.1.3 SL-1 Accident Dose Reconstructions ........................................................80 5.1.4 Occupational External Dose Issues............................................................87 5.2 Other Observations ..............................................................................................111 6.0 Overall Adequacy of the INL Site Profile as a Basis for Dose Reconstruction ..............113 6.1 Satisfying the Five Objectives .............................................................................113 6.1.1 Objective 1: Completeness of Data Sources ...........................................115 6.1.2 Objective 2: Technical Accuracy............................................................117 6.1.3 Objective 3: Adequacy of Data...............................................................119 Effective Date: Revision No. Document No. Page No. January 25, 2006 1 (Draft) SCA-TR-TASK1-0005 4 of 249 6.1.4 Objective 4: Consistency Among Site Profiles.......................................120 6.1.5 Objective 5: Regulatory Compliance ......................................................120 6.2 Usability of Site Profile for Intended Purpose .....................................................121 6.3 Unresolved Policy or Generic Technical Issues ..................................................123 7.0 References........................................................................................................................125 Attachment 1: Conference Call with NIOSH and SC&A...........................................................131 Attachment 2: Advance Questions for Site Expert Interviews ...................................................154 Attachment 3: Summary of Site Expert Interviews ....................................................................166 Attachment 4: Consistency Between Hanford, SRS, and INL Site Profiles...............................220 Attachment 5: Issue Resolution Matrix for Findings and Key Observations ..............................240 Effective Date: Revision No. Document No. Page No. January 25, 2006 1 (Draft) SCA-TR-TASK1-0005 5 of 249 ACRONYMS AND ABBREVIATIONS AEC U.S. Atomic Energy Commission AEDE Annual Effective Dose Equivalent α Alpha Particle AMWTP Advanced Mixed Waste Treatment Program ANC Aerojet Nuclear Corporation ANL Argonne National Laboratory ANL-W Argonne National Laboratory West ANP Aircraft Nuclear Propulsion ANPP Aircraft Nuclear Propulsion Program ANSI American National Standards Institute APS Atmospheric Protection System ARA Army Reactor Area (later Auxiliary Reactor Area) AREA Army Reactor Experimental Area ARMF-1 Advanced Reactivity Measurements Facility No. 1 ARMF-2 Advanced Reactivity Measurements Facility No. 2 ARVFS Army Reentry Vehicle Facility Site ATR Advanced Test Reactor ATRC Advanced Test Reactor Critical Facility β Beta Particle BORAX Boiling Water Reactor Experiment BORAX I Boiling Water Reactor Experiment No. 1 BORAX II Boiling Water Reactor Experiment No. 2 BORAX III Boiling Water Reactor Experiment No. 3 BORAX IV Boiling Water Reactor Experiment No. 4 BORAX V Boiling Water Reactor Experiment No. 5 Bq Becquerel (1 disintegration per second) C Celsius/Centigrade CA Contamination Area CAM Continuous Air Monitor CAMU Corrective Action Management Unit CAS Criticality Accident System Effective Date: Revision No. Document No. Page No. January 25, 2006 1 (Draft) SCA-TR-TASK1-0005 6 of 249 CDC Centers for Disease Control and Prevention CE Critical Experiment